With the first Casgevy revenues coming in and the company's established cystic fibrosis portfolio firing on all cylinders, Vertex brought in a quarterly haul of $2.77 billion, a 12% increase from ...

Phil Nadeau, an analyst from TD Cowen, maintained the Buy rating on Vertex Pharmaceuticals (VRTX – Research Report). The associated price ...

The adjustment reflects Vertex's strong performance in its cystic fibrosis (CF) business, which has outperformed expectations. The company's recent financial results have demonstrated the ...

Wells Fargo analyst Mohit Bansal maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $555.00. The company’s shares closed last Monday at $472.80. According to ...

Grant Thornton, one of America’s largest brands of professionals providing end-to-end audit, assurance, tax and advisory services, has been named the Vertex System Integrator Partner of the Year for ...

From a technical perspective, Vertex Pharmaceuticals (VRTX) is looking like an interesting pick, as it just reached a key level of support. VRTX recently overtook the 50-day moving average, and this ...

THIS MORNING. MATT. GOOD MORNING, ANTOINETTE AND DOUG. GOOD MORNING. SOME MAJOR CHANGES COMING TO MASSACHUSETTS NOW THAT VOTERS ARE PROJECTED TO APPROVE THREE OUT OF THE FIVE BALLOT MEASURES.

Massachusetts has been called for Vice President Kamala Harris, clinching the Bay State's 11 votes in the Electoral College. The race was called within 5 minutes of polls closing in Massachusetts ...

is the holding company for Rockland Trust Company, a full-service commercial bank headquartered in Massachusetts. Named in 2018 to The Boston Globe's “Top Places to Work” list for the 10th ...